Summary
Johnson & Johnson (JNJ) filed an 8-K on July 16, 2013, to report its financial results for the second quarter and six months ended June 30, 2013. This filing primarily serves to disseminate the official press release and supplementary financial data, providing investors with key performance metrics. The company's performance during this period, as detailed in the accompanying press release, is crucial for understanding JNJ's ongoing business trends and financial health. Investors should review the unaudited comparative supplementary sales data and condensed consolidated statement of earnings to gain insights into revenue generation, profitability, and any significant shifts in the company's financial condition. While the 8-K itself is a notification of the results, the attached exhibits contain the detailed financial information necessary for a comprehensive analysis of JNJ's operational and financial standing for the first half of 2013.
Key Highlights
- 1JNJ announced its second quarter and six months ended June 30, 2013, sales and earnings results via an 8-K filing.
- 2The filing includes a press release detailing the company's financial performance.
- 3Unaudited comparative supplementary sales data is provided for investor review.
- 4Condensed consolidated statements of earnings are included for the specified periods.
- 5This report serves as the official public disclosure of JNJ's Q2 and H1 2013 financial results.